Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001104659-21-097940
Filing Date
2021-07-30
Accepted
2021-07-30 07:39:06
Documents
56
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 6-K/A azn-20210630x6ka.htm   iXBRL 6-K/A 5211255
7 GRAPHIC azn-20210630x6ka001.jpg GRAPHIC 3235
8 GRAPHIC azn-20210630x6ka030.jpg GRAPHIC 2743
  Complete submission text file 0001104659-21-097940.txt   17578735

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA azn-20210630.xsd EX-101.SCH 76973
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE azn-20210630_cal.xml EX-101.CAL 69979
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE azn-20210630_def.xml EX-101.DEF 235759
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE azn-20210630_lab.xml EX-101.LAB 536673
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE azn-20210630_pre.xml EX-101.PRE 417862
9 EXTRACTED XBRL INSTANCE DOCUMENT azn-20210630x6ka_htm.xml XML 4518234
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-11960 | Film No.: 211130056
SIC: 2834 Pharmaceutical Preparations